Pharmacology, Toxicology, Pharmacokinetics Flashcards
Two dose-response curve response plotted on the same graph showed sigmoid curves having the same
slope and height. T curve is located to the right of the A curve. Which of the following statements is/are
correct regarding curves A an:
Response|
/A /B
Log Dose -
I. A is more effective than B
II. A is more potent than B
III. A and B have the same ceiling dose
IV. B is the graph produced when A is given with its competitive antagonist
V. B is the graph produced when A is given with its non-competitive antagonist
a. Only I and III are correct
b. Only II, III and IV are correct
c. Only II and IV are correct
d. Only III and V are correct
e. Only V is correct
Only II, III and IV are correct
Two dose-response curve plotted on the same graph showed sigmoid curves A and B, where A is at the left
of the graph with the height greater than B. Which of the following statements is/are correct regarding
curves A and B?
Response |
/A shorter/B
Log Dose-
I. A and B has equal efficacy
II. A and B have equal potency
III. B is a partial agonist of A
IV. B is the graph produced when A is given with its competitive antagonist
V. B is the graph produced when A is given with its non-competitive antagonist
a. Only I and III are correct
b. Only II, III and IV are correct
c. Only II and IV are correct
d. Only III and V are correct
e. Only V is correct
Only III and V are correct
The cumulative number of subjects who display a certain rersponse or effect to a drug is plotted on a graph
as shown below. The graph on the left represents beneficial effect while the graph on the right represents
toxic effect, what is the therapeutic index of the drug?
%Response |
100 -A -B
50 /A /B
0 /A /B
0 50 100 150 200 250 300
a.0.5
b. 1.5
c. 2.5
d.4.0
e. 5.0
5.0
An administration of one drug leads to a shift in the log dose-response curve of another drug to the left a
range in the maximal efficacy, this is called
a. Agonism
b. Partial agonism
c. Non-competitive antagonism
d. Competitive antagonism
e. Potentiation
Potentiation
The action of this drug is dependent on a colligative property
a. Mannitol
b. Cocaine
c. Reserpine
d. Furosemide
e. Losartan
Mannitol
Whiich of the following drug groups have mechanisms of action that involve binding to enzymes as target
protiens
a. Benzodiazepines
b. Barbiturates
c. Calcium channel blockers
d. Non-steroidal anti-inflammatory agents
e. Phenothiazine antipsychotics
Non-steroidal anti-inflammatory agents
Voltage-gated ion channels serve as site of actions for drugs such as
I. Diltiazem and Nifedipine
II. Lidocaine and Procaine
III. Captopril and Losartan
a. I only
b. I and II
c. III only
d. I and III
e. I, II, and III
I and II
Drugs with mechanism of action that involves Tubulin-binding leading to loss of function of the structural
protien include
a. Cyclosporine
b. Neostigmine
c. Colchicine
d. Glibenclamide
e. Metformin
Colchicine
What type of protien is primarily targeted by Digitalis glycosides when they exert their effect on the heart?
a. Receptors
b. Ion channels
c. Enzymes
d. Transporters
e. Structural protiens
Transporters
Which of the following features cahracterize nicotinic, GABA-A, and Glutamate receptors?
a. They control the movements of ions and out of the cell
b. Their action is mediated bysecondary messengers
c. They all have excitatory effect on the cell membrane
d. They are located on the cytoplasm
They control the movements of ions and out of the cell
Which of the following drugs bind to receptors located at the cell membrane?
a. Thyroid hormone
b. Prednisone
c. Estrogen
d. Insulin
e. Vitamin D
Insulin
Cyclic Adenosine Monophophate (cAMP) is generated as a secondary messenger by the action of the enzyme Adenylyl Cyclase. The substrate for the synthesis of cAMP is
a. AMD
b. ADP
c. ATP
d. GTP
e. Adenosine
ATP
Stimulation of Beta-adrenoceptor, a G-protien-linked receptor involves a generation of a secondary
messenger known as
a. IP3
b. cGTP
c. DAG
d. cAMP
e. Calcium ions
cAMP
What is the mechanism of action of Sildenafil, a drug popularly known as viagra?
a. Inhibits phosphodiesterase (PDE) leading to increase cAMP
b. Inhibits PDE leading to increase cGMP
c. Stimulates adenylyl cyclase leading to increase cAMP
d. Stimulates guanylyl cyclase leading to increase cGMP
e. Inhibits phosphodiesterase leading to increase cGMP
Inhibits PDE leading to increase cGMP
Drugs that activate the phospholipase C-inositol phosphate system such as alpha-adrenergic agonists like
phenylephrine primarily cause an increase in the intracellular levels of which ion?
a. Calcium
b. Magnesium
c. Sodium
d. Potassium
e. Chloride
Calcium